Skip to main content

Table 1 Pituitary adenoma stem cell patient isolates: Clinico-pathological data

From: The identification of human pituitary adenoma-initiating cells

Sample ID

Gender

Age

Adenoma Subtype

CD15%

CD133%

Sox2%

PA1

M

69

GH

15.92

1.82

3.55

PA2

M

72

ACTH

10.25

89.75

12.82

PA3

M

35

GH

75.15

1.2

9.53

PA4

F

66

FSH/LH

83.46

16.55

4.54

PA5

M

76

GH

7.12

0.54

3.11

PA6

M

53

FSH/PRL

4.11

23.13

11.35

PA7

F

26

GH/PRL

2.59

47.98

28.36

PA8

F

52

Null Cell

62.71

1.07

2.24

PA9

F

76

LH

4.51

13.11

9.23

PA10

F

60

Null Cell

80.72

19.29

2.74

PA11

M

80

Null Cell

84.22

1.99

2.05

PA12

M

83

Null Cell

14.98

11.32

4.52

PA13

M

80

Null Cell

72.70

1.52

2.74

PA14

M

48

GH/PRL

7.06

3.92

6.63

PA15

M

51

GH/PRL

3.11

1.42

3.13

PA16

M

70

Null Cell

53.12

0.45

1.19

PA17

M

42

GH

99.56

0.47

19.24

PA18

M

64

Null Cell

7.23

12.21

7.31

PA19

M

52

Null Cell

98.86

0.96

15.07

PA20

M

72

GH

9.86

2.26

1.78

PA21

F

71

Null Cell

62.12

1.11

1.42

PA22

F

71

Null Cell

44.15

1.78

2.51

  1. PA pituitary adenoma, M Male, F Female, GH Growth Hormone, ACTH Adrenocorticotropic Hormone, PRL Prolactin, FSH Follicle-Stimulating Hormone, LH Luteinizing Hormone